Stable angina of coronary artery disease
Conditions
Interventions
Treatment group:Astragaloside IV glucose injection for 2 weeks
Control group:Salvia miltiorrhize Injection for 2 weeks
Sponsors
Teaching Hospital of Chengdu University of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
40 Years to 70 Years
Inclusion criteria
Inclusion criteria: (1) Patients who fit the diagnostic criteria for angina of coronaryheart disease; (2) Patients who fit the diagnostic criteria for stable effort anginaof coronary heart disease; (3) Effort angina level I, II III; (4) Attack frequency at >2 per week; (5) Electrocardiogram (ECG): S-T segment shift is less than or equalto 0.1 mv and/or along with an inverted T wave in the prominent Rwave lead by a depth of more than 0.2 mv; or electrocardiogram: S-Tsegment shift is less than or equal to 0.05 mv, or less than 0.1 mvwith a positive treadmill exercise test; (6) Age: male: 40-70 years, female: 45-70 years; (7) patients who signed the consent forms.
Exclusion criteria
Exclusion criteria: (1) Acute myocardial infarction, menopaul syndrome, hyperthyroidism, cervical spondylosis, billiard disease, chest pain caused by stomach or esophagus reflux; (2) Hypertensive patients with blood pressure greater than or equal to 160/100 after antihypertensive drug treatment, severe cardiopulmonary dysfunction, severe arrhythmia (atrial fibrillation, atrial flutter, paroxysmal ventricular tachycardia), primary liver, kidney or hematopoietic disease, mental illness; (3) Six months within coronary artery bypass or other surgical intervention; (4) Diabetes; (5) Allergies known allergy to Astragalus; (6) Alcohol allergy; (7) Use of drugs known to have severe impact on liver kidney function within one month; (8) Patients involved in other clinical trials within one month.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Number of angina attack;Angina duration;Angina pain;Nitroglycerin consumption; | — |
Countries
China
Contacts
Public ContactHong Ding
Outcome results
None listed